{"id":1012180,"date":"2026-10-21T07:12:41","date_gmt":"2026-10-21T11:12:41","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-second-fiscal-quarter-ended-september-30-2026-and-provide-business-update-on-monday-november-9-2026\/"},"modified":"2026-10-21T07:12:41","modified_gmt":"2026-10-21T11:12:41","slug":"immunovant-to-report-financial-results-for-the-second-fiscal-quarter-ended-september-30-2026-and-provide-business-update-on-monday-november-9-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-second-fiscal-quarter-ended-september-30-2026-and-provide-business-update-on-monday-november-9-2026\/","title":{"rendered":"Immunovant\u00a0to\u00a0Report Financial Results for the\u00a0Second\u00a0Fiscal Quarter Ended\u00a0September\u00a030, 2026,\u00a0and Provide Business Update\u00a0on\u00a0Monday, November 9, 2026"},"content":{"rendered":"<div class=\"mw_release\">\n<p>DURHAM, N.C., Oct.  21, 2026  (GLOBE NEWSWIRE) &#8212; Immunovant, Inc. (Nasdaq:\u00a0<strong>IMVT<\/strong>) today announced that it will report its financial results for the second fiscal quarter ended September 30, 2026 on Monday, November 9, 2026 before the market opens. Roivant Sciences Ltd. (Nasdaq: ROIV), Immunovant\u2019s majority stockholder, will host a live conference call and webcast at 8:00 a.m. ET that same day, which will include a business update for Immunovant.<\/p>\n<p>To access the\u00a0Roivant conference call by phone, please register online using this <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=BxXuDIME_bEAs_SGAnCTuAD1E8zwvCCs8Ouh8PsDrUZLHY2-gxdW6Ykh80z-u1hI_pOTmT1P71dhydTt5zP0rTMOR0iWSrAw1VUYQzs9eCsiJgymfU3QT88ZyyO5ViVg14OSxuycYdGO6n-9nthFk6BOg4C9m_C5DrvC4XnNIr4=\" rel=\"nofollow\" target=\"_blank\"><u>registration link<\/u><\/a><u>.<\/u> The presentation and webcast details will also be available under \u201cNews &amp; Events\u201d in the Investors section of the Immunovant website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4ECj77kkwUuu4NgKqPxJhPOFUbBzjG_o6vkqzI1VwV51kT6nHfSwyR2exWLQz8IoL_tOGqS-HW20gD_M0MvNhSxuTdBav6CYNojFCAyntQ_neWS9MZkscMZfkC7w8AfwN3OUCZg6YPfDHld6kaIjk7dvu0xvPLZLbibvRvKpjdc_EcOGewJcedEPKJKSNDwqLB8AqUurAtt3hQA2QEK9pCdmzUBE6CLmmr6DKBliRiUe2hmzKRjO8FufVYkIZpJICyNaRwbhyqK_3F5QHAsNj5SwYIQTS4XpS3tKedjP7x3kEE9CFLBDYosdZ8_TZw6WOhqyqSN1e0VBOy7UOmYaW0UG350RaEUTO-brS0lTBZuLEUZAAtLAdwIhs-bXgqoJRbwBoEjRxxPXWm6nZnheXKKMvyjlY18_j1cyta7FrFlGCzITaRfUe21KJPA8ma9_ZH3rkrRlU6k9A_HD9bx9Xw==\" rel=\"nofollow\" target=\"_blank\"><u>https:\/\/www.immunovant.com\/investors\/news-events\/ir-calendar<\/u><\/a>. The archived webcast will be available on Immunovant\u2019s website after the conference call.<\/p>\n<p>\n        <strong>About\u00a0Immunovant<\/strong>\u00a0<\/p>\n<p>Immunovant, Inc. is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases and is a majority-owned subsidiary of Roivant. As a trailblazer in anti-FcRn technology, the Company is developing innovative, targeted therapies to meet the complex and variable needs of people with autoimmune diseases. For\u00a0additional\u00a0information on the Company, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=z-Q1pZabxMVhlXSHz1jyseN2XbYiCRUAKLPi9SkBQJ1xA3YbnSKfEYgS1ajbjwJ9FJdhfOLgBSpEo06-miBrIT05jzm6q_wDebiZJYhxE7ILWfDGn08gvwlv7mhi4SabLu9V62jimcX_FJht67KQ8yeDfFF3OO88yNkeXu8cnVSWuqQQzPPqNp-7GSu7PQ5j0CsuMX5eO-zdxMgU5tll7RlYXXj-195dpiF3T_PpR14fliXUKB6xi1XROhsmt02V6PBe2zHky-Y3Bt7EV3tuM9_x7c6D4IPsaMn5OwMU4LGJV9m21nhxnWdDi5lTBmP0IpDJdC9EIsA-3cnPkdUBXx64ieo1CL-LRKjsBA099ZYlnwKuU7-kqWMuvvbOuJfzPMjaGyAwH7hHSTyVZQoo5h4_yF2T6-VWNPGXFBGczZw=\" rel=\"nofollow\" target=\"_blank\">immunovant.com<\/a>.\u00a0<\/p>\n<p>\n        <strong>Contacts:<\/strong>\u00a0<\/p>\n<p>\n        <u>Investors<\/u><br \/>\n        <br \/>Keyur Parekh <br \/>keyur.parekh@roivant.com<\/p>\n<p>\n        <u>Media<\/u><br \/>\n        <br \/>Stephanie Lee <br \/>stephanie.lee@roivant.com<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1MDExNyM3OTA3ODY2IzIxMjU4NDQ=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/Zjg4MWQyYTQtNjcyNC00YTQwLTk5YjktMTkyYjA4YWM4Y2JjLTExMzc0MTUtMjAyNi0xMC0yMS1lbg==\/tiny\/Immunovant-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>DURHAM, N.C., Oct. 21, 2026 (GLOBE NEWSWIRE) &#8212; Immunovant, Inc. (Nasdaq:\u00a0IMVT) today announced that it will report its financial results for the second fiscal quarter ended September 30, 2026 on Monday, November 9, 2026 before the market opens. Roivant Sciences Ltd. (Nasdaq: ROIV), Immunovant\u2019s majority stockholder, will host a live conference call and webcast at 8:00 a.m. ET that same day, which will include a business update for Immunovant. To access the\u00a0Roivant conference call by phone, please register online using this registration link. The presentation and webcast details will also be available under \u201cNews &amp; Events\u201d in the Investors section of the Immunovant website at https:\/\/www.immunovant.com\/investors\/news-events\/ir-calendar. The archived webcast will be available on Immunovant\u2019s website after the conference call. About\u00a0Immunovant\u00a0 &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-second-fiscal-quarter-ended-september-30-2026-and-provide-business-update-on-monday-november-9-2026\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Immunovant\u00a0to\u00a0Report Financial Results for the\u00a0Second\u00a0Fiscal Quarter Ended\u00a0September\u00a030, 2026,\u00a0and Provide Business Update\u00a0on\u00a0Monday, November 9, 2026&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1012180","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Immunovant\u00a0to\u00a0Report Financial Results for the\u00a0Second\u00a0Fiscal Quarter Ended\u00a0September\u00a030, 2026,\u00a0and Provide Business Update\u00a0on\u00a0Monday, November 9, 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-second-fiscal-quarter-ended-september-30-2026-and-provide-business-update-on-monday-november-9-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Immunovant\u00a0to\u00a0Report Financial Results for the\u00a0Second\u00a0Fiscal Quarter Ended\u00a0September\u00a030, 2026,\u00a0and Provide Business Update\u00a0on\u00a0Monday, November 9, 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"DURHAM, N.C., Oct. 21, 2026 (GLOBE NEWSWIRE) &#8212; Immunovant, Inc. (Nasdaq:\u00a0IMVT) today announced that it will report its financial results for the second fiscal quarter ended September 30, 2026 on Monday, November 9, 2026 before the market opens. Roivant Sciences Ltd. (Nasdaq: ROIV), Immunovant\u2019s majority stockholder, will host a live conference call and webcast at 8:00 a.m. ET that same day, which will include a business update for Immunovant. To access the\u00a0Roivant conference call by phone, please register online using this registration link. The presentation and webcast details will also be available under \u201cNews &amp; Events\u201d in the Investors section of the Immunovant website at https:\/\/www.immunovant.com\/investors\/news-events\/ir-calendar. The archived webcast will be available on Immunovant\u2019s website after the conference call. About\u00a0Immunovant\u00a0 &hellip; Continue reading &quot;Immunovant\u00a0to\u00a0Report Financial Results for the\u00a0Second\u00a0Fiscal Quarter Ended\u00a0September\u00a030, 2026,\u00a0and Provide Business Update\u00a0on\u00a0Monday, November 9, 2026&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-second-fiscal-quarter-ended-september-30-2026-and-provide-business-update-on-monday-november-9-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-21T11:12:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1MDExNyM3OTA3ODY2IzIxMjU4NDQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunovant-to-report-financial-results-for-the-second-fiscal-quarter-ended-september-30-2026-and-provide-business-update-on-monday-november-9-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunovant-to-report-financial-results-for-the-second-fiscal-quarter-ended-september-30-2026-and-provide-business-update-on-monday-november-9-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Immunovant\u00a0to\u00a0Report Financial Results for the\u00a0Second\u00a0Fiscal Quarter Ended\u00a0September\u00a030, 2026,\u00a0and Provide Business Update\u00a0on\u00a0Monday, November 9, 2026\",\"datePublished\":\"2026-10-21T11:12:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunovant-to-report-financial-results-for-the-second-fiscal-quarter-ended-september-30-2026-and-provide-business-update-on-monday-november-9-2026\\\/\"},\"wordCount\":219,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunovant-to-report-financial-results-for-the-second-fiscal-quarter-ended-september-30-2026-and-provide-business-update-on-monday-november-9-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1MDExNyM3OTA3ODY2IzIxMjU4NDQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunovant-to-report-financial-results-for-the-second-fiscal-quarter-ended-september-30-2026-and-provide-business-update-on-monday-november-9-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunovant-to-report-financial-results-for-the-second-fiscal-quarter-ended-september-30-2026-and-provide-business-update-on-monday-november-9-2026\\\/\",\"name\":\"Immunovant\u00a0to\u00a0Report Financial Results for the\u00a0Second\u00a0Fiscal Quarter Ended\u00a0September\u00a030, 2026,\u00a0and Provide Business Update\u00a0on\u00a0Monday, November 9, 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunovant-to-report-financial-results-for-the-second-fiscal-quarter-ended-september-30-2026-and-provide-business-update-on-monday-november-9-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunovant-to-report-financial-results-for-the-second-fiscal-quarter-ended-september-30-2026-and-provide-business-update-on-monday-november-9-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1MDExNyM3OTA3ODY2IzIxMjU4NDQ=\",\"datePublished\":\"2026-10-21T11:12:41+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunovant-to-report-financial-results-for-the-second-fiscal-quarter-ended-september-30-2026-and-provide-business-update-on-monday-november-9-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunovant-to-report-financial-results-for-the-second-fiscal-quarter-ended-september-30-2026-and-provide-business-update-on-monday-november-9-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunovant-to-report-financial-results-for-the-second-fiscal-quarter-ended-september-30-2026-and-provide-business-update-on-monday-november-9-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1MDExNyM3OTA3ODY2IzIxMjU4NDQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1MDExNyM3OTA3ODY2IzIxMjU4NDQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immunovant-to-report-financial-results-for-the-second-fiscal-quarter-ended-september-30-2026-and-provide-business-update-on-monday-november-9-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Immunovant\u00a0to\u00a0Report Financial Results for the\u00a0Second\u00a0Fiscal Quarter Ended\u00a0September\u00a030, 2026,\u00a0and Provide Business Update\u00a0on\u00a0Monday, November 9, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Immunovant\u00a0to\u00a0Report Financial Results for the\u00a0Second\u00a0Fiscal Quarter Ended\u00a0September\u00a030, 2026,\u00a0and Provide Business Update\u00a0on\u00a0Monday, November 9, 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-second-fiscal-quarter-ended-september-30-2026-and-provide-business-update-on-monday-november-9-2026\/","og_locale":"en_US","og_type":"article","og_title":"Immunovant\u00a0to\u00a0Report Financial Results for the\u00a0Second\u00a0Fiscal Quarter Ended\u00a0September\u00a030, 2026,\u00a0and Provide Business Update\u00a0on\u00a0Monday, November 9, 2026 - Market Newsdesk","og_description":"DURHAM, N.C., Oct. 21, 2026 (GLOBE NEWSWIRE) &#8212; Immunovant, Inc. (Nasdaq:\u00a0IMVT) today announced that it will report its financial results for the second fiscal quarter ended September 30, 2026 on Monday, November 9, 2026 before the market opens. Roivant Sciences Ltd. (Nasdaq: ROIV), Immunovant\u2019s majority stockholder, will host a live conference call and webcast at 8:00 a.m. ET that same day, which will include a business update for Immunovant. To access the\u00a0Roivant conference call by phone, please register online using this registration link. The presentation and webcast details will also be available under \u201cNews &amp; Events\u201d in the Investors section of the Immunovant website at https:\/\/www.immunovant.com\/investors\/news-events\/ir-calendar. The archived webcast will be available on Immunovant\u2019s website after the conference call. About\u00a0Immunovant\u00a0 &hellip; Continue reading \"Immunovant\u00a0to\u00a0Report Financial Results for the\u00a0Second\u00a0Fiscal Quarter Ended\u00a0September\u00a030, 2026,\u00a0and Provide Business Update\u00a0on\u00a0Monday, November 9, 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-second-fiscal-quarter-ended-september-30-2026-and-provide-business-update-on-monday-november-9-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-10-21T11:12:41+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1MDExNyM3OTA3ODY2IzIxMjU4NDQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-second-fiscal-quarter-ended-september-30-2026-and-provide-business-update-on-monday-november-9-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-second-fiscal-quarter-ended-september-30-2026-and-provide-business-update-on-monday-november-9-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Immunovant\u00a0to\u00a0Report Financial Results for the\u00a0Second\u00a0Fiscal Quarter Ended\u00a0September\u00a030, 2026,\u00a0and Provide Business Update\u00a0on\u00a0Monday, November 9, 2026","datePublished":"2026-10-21T11:12:41+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-second-fiscal-quarter-ended-september-30-2026-and-provide-business-update-on-monday-november-9-2026\/"},"wordCount":219,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-second-fiscal-quarter-ended-september-30-2026-and-provide-business-update-on-monday-november-9-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1MDExNyM3OTA3ODY2IzIxMjU4NDQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-second-fiscal-quarter-ended-september-30-2026-and-provide-business-update-on-monday-november-9-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-second-fiscal-quarter-ended-september-30-2026-and-provide-business-update-on-monday-november-9-2026\/","name":"Immunovant\u00a0to\u00a0Report Financial Results for the\u00a0Second\u00a0Fiscal Quarter Ended\u00a0September\u00a030, 2026,\u00a0and Provide Business Update\u00a0on\u00a0Monday, November 9, 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-second-fiscal-quarter-ended-september-30-2026-and-provide-business-update-on-monday-november-9-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-second-fiscal-quarter-ended-september-30-2026-and-provide-business-update-on-monday-november-9-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1MDExNyM3OTA3ODY2IzIxMjU4NDQ=","datePublished":"2026-10-21T11:12:41+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-second-fiscal-quarter-ended-september-30-2026-and-provide-business-update-on-monday-november-9-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-second-fiscal-quarter-ended-september-30-2026-and-provide-business-update-on-monday-november-9-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-second-fiscal-quarter-ended-september-30-2026-and-provide-business-update-on-monday-november-9-2026\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1MDExNyM3OTA3ODY2IzIxMjU4NDQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1MDExNyM3OTA3ODY2IzIxMjU4NDQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immunovant-to-report-financial-results-for-the-second-fiscal-quarter-ended-september-30-2026-and-provide-business-update-on-monday-november-9-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Immunovant\u00a0to\u00a0Report Financial Results for the\u00a0Second\u00a0Fiscal Quarter Ended\u00a0September\u00a030, 2026,\u00a0and Provide Business Update\u00a0on\u00a0Monday, November 9, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1012180","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1012180"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1012180\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1012180"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1012180"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1012180"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}